Karim Galil, founder of Mendel.ai, speaks at MIT 2024 about how Mendel is pushing the boundaries of AI in healthcare. He discusses how Mendel’s platform, with its ability to clinically reason, goes beyond traditional LLMs by understanding the context within medical records—differentiating between symptoms and side effects, for instance. This capability enables faster, more accurate insights, particularly in oncology, transforming how patient data is analyzed and used to improve care.

Join Karim Galil, CEO of Mendel, as he delves into the transformative power of Clinical AI in this enlightening talk at MIT 2024. Discover how Mendel's advanced AI technology is revolutionizing clinical trials, patient data analysis, and healthcare efficiency. Learn about the unique attributes of Clinical AI, including its ability to understand patient journeys, differentiate between symptoms and side effects, and ensure data accuracy without hallucinations.